Key details
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Collaborators
Shanghai Vitalgen BioPharma Co., Ltd.
Enrollment target
~2 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
3 Years – 35 Years
Last updated October 2023